HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Supplementary materials and methods Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Woischnik, M. Articles by Griese, M. Search for Related Content PubMed PubMed Citation Articles by Woischnik, M. Articles by Griese, M.

Cathepsin H and napsin A are active in the alveoli and increased in alveolar proteinosis

¹ Children’s Hospital, Ludwig-Maximilians-University, Munich, ³ ASKLEPIOS Fachkliniken, Zentrum für Pneumologie und Thoraxchirurgie, München-Gauting, Gauting, Germany, and ² Hôpital Necker Enfants Malades, Service de Pneumologie et d'Allergologie Pédiatriques, Paris, France.

CORRESPONDENCE: M. Griese, Children’s Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, D-80337 Munich, Germany. Fax: 49 8951607872. E-mail: Matthias.griese{at}med.uni-muenchen.de

Keywords: Alveolar proteinosis, cathepsin H, napsin A, surfactant protein-B, surfactant protein-C

Received: July 2, 2007
Accepted January 4, 2008

Pulmonary alveolar proteinosis (PAP) is a group of rare diseases with disturbed homeostasis of alveolar surfactant. While 90% of the primary adult forms are caused by granulocyte-macrophage colony-stimulating factor autoantibodies, the underlying cause of the juvenile form remains unknown. In order to distinguish primary from secondary effects in the pathogenesis of these two forms, the present authors studied the surfactant protein processing proteases napsin A and cathepsin H.

In total, 16 controls, 20 patients with juvenile PAP and 13 adults with idiopathic PAP were enrolled. Amounts and activities of the proteases in the bronchoalveolar lavage fluid (BALF) were determined by immunoblotting and specific substrate cleavage.

Both proteases were present and active in BALF from controls and increased in juvenile and adult PAP patients. The amount of active cathepsin H in relation to total cathepsin H was increased in PAP patients compared with controls. Cystatin C, the physiological inhibitor of cathepsin H in the alveolar space, was not increased to the same degree as cathepsin H, resulting in an imbalance of inhibitor to protease in the alveolar space.

A general defect in napsin A or cathepsin H expression or activity was not the specific cause for abnormal surfactant accumulation in juvenile pulmonary alveolar proteinosis.